Literature DB >> 18986279

The pneumonia severity index: a decade after the initial derivation and validation.

Drahomir Aujesky1, Michael J Fine.   

Abstract

The prognosis of community-acquired pneumonia ranges from rapid resolution of symptoms and full recovery of functional status to the development of severe medical complications and death. The pneumonia severity index is a rigorously studied prediction rule for prognosis that objectively stratifies patients into quintiles of risk for short-term mortality on the basis of 20 demographic and clinical variables routinely available at presentation. The pneumonia severity index was derived and validated with data on >50,000 patients with community-acquired pneumonia by use of well-accepted methodological standards and is the only pneumonia decision aid that has been empirically shown to safely increase the proportion of patients given treatment in the outpatient setting. Because of its prognostic accuracy, methodological rigor, and effectiveness and safety as a decision aid, the pneumonia severity index has become the reference standard for risk stratification of community-acquired pneumonia.

Entities:  

Mesh:

Year:  2008        PMID: 18986279     DOI: 10.1086/591394

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study.

Authors:  Damien Basille; Nathalie Plouvier; Charlotte Trouve; Pierre Duhaut; Claire Andrejak; Vincent Jounieaux
Journal:  Lung       Date:  2016-12-22       Impact factor: 2.584

2.  Audit of physicians' adherence to a preprinted order set for community-acquired pneumonia.

Authors:  Curt T Fowkes; Carol Gee; Tammy Bluemink; Dana Cole; Barbara L Falkner; Abu A Hamour
Journal:  Can J Hosp Pharm       Date:  2010-07

Review 3.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

Review 4.  Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review.

Authors:  Maguy Saffouh El Hajj; Ricky D Turgeon; Kyle John Wilby
Journal:  Int J Clin Pharm       Date:  2017-01-05

5.  Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.

Authors:  So-Youn Park; Seunghee Baek; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Heungsup Sung; Mi-Na Kim; Dae-Young Kim; Jung-Hee Lee; Je-Hwan Lee; Kyoo-Hyung Lee; Sung-Han Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

6.  Validation and Comparison of Seven Mortality Prediction Models for Hospitalized Patients With Acute Decompensated Heart Failure.

Authors:  Tara Lagu; Penelope S Pekow; Meng-Shiou Shieh; Mihaela Stefan; Quinn R Pack; Mohammad Amin Kashef; Auras R Atreya; Gregory Valania; Mara T Slawsky; Peter K Lindenauer
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

7.  Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.

Authors:  Thomas M File; Elizabeth Alexander; Lisa Goldberg; Anita F Das; Christian Sandrock; Susanne Paukner; Gregory J Moran
Journal:  BMC Pulm Med       Date:  2021-05-08       Impact factor: 3.317

8.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

9.  Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa.

Authors:  Carrie Reed; Shabir A Madhi; Keith P Klugman; Locadiah Kuwanda; Justin R Ortiz; Lyn Finelli; Alicia M Fry
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

10.  Soluble form of suppression of tumorigenicity-2 predicts clinical stability of inpatients with community-acquired pneumonia.

Authors:  Yifeng Zeng; Mingshan Xue; Teng Zhang; Shixue Sun; Runpei Lin; Ning Li; Peiyan Zheng; Yingjie Zhen; Haisheng Hu; Xiaohua Douglas Zhang; Baoqing Sun
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.